Biomarin Pharmaceutical Inc

BMRNNASDAQ · US

Holders

DISCLOSEDQuarterly
Oaktree Capital Management
Biomarin Pharmaceutical Inc · NASDAQ
64,025,000 sh · $62.4M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Oaktree Capital Management
Biomarin Pharmaceutical Inc · NASDAQ
55,985,000 sh · $54.0M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Oaktree Capital Management
Biomarin Pharmaceutical Inc · NASDAQ
42,118,000 sh · $40.5M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Oaktree Capital Management
Biomarin Pharmaceutical Inc · NASDAQ
19,719,000 sh · $18.7M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Oaktree Capital Management
Biomarin Pharmaceutical Inc · NASDAQ
1,481,000 sh · $1.4M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Biomarin Pharmaceutical Inc · NASDAQ
5,178,000 sh · $4.9M
Filed 30 Jun 2024SEC 13Fview source